Direxion Daily S&P Biotech Bull 3x Shares (LABU) Holdings $62.76 -4.38 (-6.52%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$63.13 +0.37 (+0.59%) As of 07/18/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Top 50 LABU HoldingsRankCompanyCurrent PriceWeightShares Held1Dreyfus Govt Cash Man InsN/A17.55%103,409,3792Goldman Sachs Sterling FixInc Port IncN/A12.81%75,449,0933Goldman Sachs Fin Gov 465 InstitutN/A10.23%60,281,1504S&P Biotechnology Select Industry Index SwapN/A7.43%99,3525Dreyfus Trsry Securities Cash MgmtN/A5.39%31,731,6436INSMInsmed$102.56-1.5%2.25%129,1547ALNYAlnylam Pharmaceuticals$320.53-1.3%2.07%39,4238NTRANatera$138.90-3.1%1.93%66,1869BPMCBlueprint Medicines$129.461.91%87,86610NBIXNeurocrine Biosciences$132.02-1.6%1.88%87,673 Get the Latest News and Ratings for LABU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. 11EXASExact Sciences$50.46-3.4%1.86%206,31912INCYIncyte$67.86-1.6%1.64%141,17713GILDGilead Sciences$108.22-0.5%1.54%83,88414UTHRUnited Therapeutics$292.01-1.8%1.54%31,12615AMGNAmgen$294.76-1.2%1.50%30,60916BIIBBiogen$124.99-2.9%1.47%68,18717VRTXVertex Pharmaceuticals$459.81-0.7%1.44%19,30618ABBVAbbVie$189.26-1.1%1.42%45,08919EXELExelixis$44.47-0.9%1.40%203,63320MDGLMadrigal Pharmaceuticals$334.13-4.2%1.28%26,47221BBIOBridgeBio Pharma$46.51-0.5%1.27%178,81722MRNAModerna$31.26-2.9%1.20%273,13123REGNRegeneron Pharmaceuticals$542.52-1.4%1.20%13,86624BMRNBioMarin Pharmaceutical$57.29-1.9%1.08%115,84325CashN/A1.00%5,876,91526IONSIonis Pharmaceuticals$41.76-1.0%0.99%155,91727TGTXTG Therapeutics$37.91-3.3%0.98%160,89728CRSPCRISPR Therapeutics$65.13+18.2%0.97%129,19529RVMDRevolution Medicines$38.30-1.9%0.97%144,60030HALOHalozyme Therapeutics$56.45-2.4%0.88%98,29731ROIVRoivant Sciences$11.44-1.8%0.85%438,55432SWTXSpringWorks Therapeutics$46.990.78%98,14133CYTKCytokinetics$37.23-4.3%0.72%130,47934VKTXViking Therapeutics$32.01-0.2%0.72%162,57935SMMTSummit Therapeutics$26.20-5.2%0.71%203,24736ACADACADIA Pharmaceuticals$22.56+0.0%0.68%177,19637ALKSAlkermes$29.22-0.5%0.66%133,08738PCVXVaxcyte$36.21-3.1%0.65%116,61039RNAAvidity Biosciences$33.76-0.8%0.64%128,11940AKROAkero Therapeutics$52.08-4.1%0.60%65,552A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.41ADMAADMA Biologics$16.73-4.9%0.59%197,59642NUVLNuvalent$83.40-2.7%0.58%45,29443SRRKScholar Rock$40.72-5.0%0.57%98,80044SLNOSoleno Therapeutics$87.20-0.5%0.56%41,02345ACLXArcellx$67.59-4.7%0.55%51,75546RYTMRhythm Pharmaceuticals$89.20-1.6%0.54%51,06847TWSTTwist Bioscience$35.17-1.9%0.52%87,83648RAREUltragenyx Pharmaceutical$26.31-4.0%0.50%78,57149AGIOAgios Pharmaceuticals$40.00-0.9%0.48%82,83250KRYSKrystal Biotech$147.49-1.8%0.48%21,388 Geographic ExposureUnited States63.3%Switzerland1.3%Bermuda1.1%Ireland0.8%Virgin Islands, British0.3%Currency ExposureUSD342.7%Sector ExposureHealth Care66.1%Consumer Discretionary0.5%Biotechnology0.2%Energy0.1%Industry ExposureBiotechnology62.5%Health Care Equipment & Supplies2.5%Health Care Providers & Services1.4%Distributors0.5%Renewable Energy0.1%Diversified Consumer Services0.1%SubIndustry ExposureBiotechnology62.5%Life Sciences Tools & Services2.3%Health Care Services1.4%Pharmaceuticals0.5%Health Care Equipment0.1%Renewable Energy Equipment0.1%Health Care Supplies0.1%Coupon Exposure4-643.8%Maturity Exposure20-30231.8% Related Companies and Tools Related Companies IHF Holdings PPH Holdings IHE Holdings RSPH Holdings FXH Holdings BBH Holdings RYH Holdings PJP Holdings PBE Holdings FBT Holdings This page (NYSEARCA:LABU) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts